Disease Info Card

Colorectal Cancer Metastatic

Information about Colorectal Cancer Metastatic: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Colorectal Cancer Metastatic

Most recent studies have shown that Colorectal Cancer Metastatic shares some biological mechanisms with adenocarcinoma, carcinoma, colonic-neoplasms, colorectal-cancer, colorectal-neoplasms, diarrhea, hemorrhage, liver-neoplasms, lung-neoplasms, malignant-neoplasms, malignant-tumor-of-colon, metastatic-malignant-neoplasm-to-the-liver, nausea, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, primary-neoplasm, rectal-neoplasms, tumor-angiogenesis, vomiting.

Among the many pathways, these few ones have gauged particular interests from scientists studying Colorectal Cancer Metastatic, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Cycle, Cell Death, Cell Growth, Cell Proliferation, Circadian Rhythm, Coagulation, Dna Repair, Drug Resistance, Excretion, Hypersensitivity, Immune Response, Localization, Methylation, Mismatch Repair, Pathogenesis, Secretion, Transport, Wound Healing

Quite a number of genes have been found to play important roles in Colorectal Cancer Metastatic, such as ADAMTS13, BRAF, CEACAM5, CEACAM7, EGF, EGFR, FANCA, FXN, KRAS, MID1, PGR, PSG2, SH3BP4, STK36, TMEM37, TYMS, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.